← All trials
NCT07065032
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 19, 2024
- Primary completion
- Jul 22, 2024
- Completion date
- Aug 5, 2024
- First posted
- Jul 15, 2025
- Last posted
- Jul 15, 2025
- Enrollment
- 27
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing QL Biopharmaceutical Co.,LtdLead sponsor
- Qingdao UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.